Compare ACON & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | MITQ |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Telecommunications Equipment |
| Sector | Technology | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.2M |
| IPO Year | 2022 | 2019 |
| Metric | ACON | MITQ |
|---|---|---|
| Price | $1.99 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.7K | ★ 104.9K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | 70.00 |
| EPS | N/A | ★ N/A |
| Revenue | $75,730.00 | ★ $20,139,000.00 |
| Revenue This Year | $44.55 | N/A |
| Revenue Next Year | $123.97 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 65.62 | N/A |
| 52 Week Low | $1.85 | $0.42 |
| 52 Week High | $9.36 | $1.05 |
| Indicator | ACON | MITQ |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 43.49 |
| Support Level | N/A | $0.52 |
| Resistance Level | $3.54 | $0.61 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 15.18 | 20.48 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.